Both in Pharmaceuticals
Neurogene vs Capricor Therapeutics
Over the past year NGNE returned −19.9% and CAPR returned +7.4%; their daily moves had a correlation of 0.13.
NGNE −19.9% CAPR +7.4%Growth of $1, one year, split-adjusted
| Metric | NGNE | CAPR |
|---|---|---|
| Price | $23.25 | $6.71 |
| Market cap | $465.3M | $390.1M |
| Today | −2.92% | −7.70% |
| 1 month | −28.3% | −28.8% |
| 6 months | −16.5% | −80.7% |
| Year to date | +12.9% | −76.7% |
| 1 year | −32.4% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.4M | $237.9M |
| Dividend yield | — | — |
| Volatility (60d) | 63.1% | 269.5% |
| Short % of float | 38.6% | 45.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).